IP Library Granted Patent US 9,402,571
Granted Patent B2
US 9,402,571 · App. 14/190,294 · Granted Aug 2, 2016

Biological tissue function analysis

Inventor: Hongxuan Zhang (Palatine, IL)
Assignee: Siemens Medical Solutions USA, Inc.
A61B5/14551A61B5/02416A61B5/7264A61B5/7282A61B5/021A61B5/046A61B5/0464A61B5/7203A61B5/7207A61B5/746
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,402,571
App. No.
14/190,294
Granted
Aug 2, 2016
Kind
B2
Abstract

Disclosed herein is a framework for facilitating biological tissue function analysis. In accordance with one aspect, saturation of hemoglobin with oxygen (SPO2) signal data is synchronized with respiration signal data. One or more waveform parameters may be generated based on the synchronized SPO2 signal data and the respiration signal data. One or more respiration-SPO2 parameters may then be determined based on the one or more waveform parameters and used to characterize the biological tissue function.

Claims (38)

1. A method for heart function analysis, comprising:

receiving, by a processor, patient signal data from a patient, the patient signal data including SPO2 signal data received from an oximeter and indicative of saturation of hemoglobin with oxygen and respiration signal data received from a respiratory monitor;

using a signal data analysis unit to synchronize the SPO2 signal data by gating the SPO2 signal using the respiration signal to select a first cycle of the SPO2 signal which corresponds to exhalation of the patient and a second cycle of the SPO2 signal which corresponds to inspiration of the patient;

determining, by the processor, one or more waveform parameters based on the selected cycles of the synchronized SPO2 signal data;

determining, by the processor, one or more respiration-SPO2 parameters based on the one or more waveform parameters;

determining a heart function based on the one or more respiration-SPO2 parameters; and

generating a patient report indicating the determined heart function.

2. The method of claim 1 wherein determining the one or more waveform parameters comprises extracting morphology information associated with the synchronized SPO2 signal.

3. The method of claim 2 wherein extracting the morphology information comprises detecting peaks or valleys of a waveform within the synchronized SPO2 signal and determining time durations between the peaks or valleys.

4. The method of claim 3 wherein determining the one or more respiration-SPO2 parameters comprises calculating a cycle ratio based on a respiration signal cycle time duration and a mean time duration of SPO2 signal cycles within the synchronized SPO2 signal.

5. The method of claim 3 wherein determining the one or more respiration-SPO2 parameters comprises calculating a timing ratio based on a respiration signal cycle time duration and a mean value of the determined time durations associated with the synchronized SPO2 signal.

6. The method of claim 1 wherein determining the one or more waveform parameters comprises determining an amplitude integration parameter associated with the selected first or second cycle.

7. The method of claim 6 wherein determining the one or more respiration-SPO2 parameters comprises calculating an amplitude integration index based on a first amplitude integration parameter associated with the selected first cycle and a second amplitude integration parameter associated with the selected second cycle.

8. The method of claim 1 wherein determining the one or more waveform parameters comprises determining an energy integration parameter associated with the selected first or second cycle.

9. The method of claim 8 wherein determining the one or more respiration-SPO2 parameters comprises calculating an energy integration index based on a first energy integration parameter associated with the selected first cycle and a second energy integration parameter associated with the selected second cycle.

10. The method of claim 1 wherein determining the heart function comprises characterizing cardiac arrhythmia.

11. The method of claim 10 wherein characterizing the cardiac arrhythmia comprises identifying a severity, type or location of the cardiac arrhythmia.

12. The method of claim 1 further comprising performing a statistical evaluation of the one or more respiration-SPO2 parameters over a plurality of heart cycles.

13. The method of claim 12 wherein performing the statistical evaluation comprises calculating a mean, standard deviation, variation or variability.

14. The method of claim 1 further comprising acquiring the SPO2 signal data by pulse oximetry.

15. The method of claim 1 further comprising acquiring the respiration signal data by using a capnograph.

16. The method of claim 1 further comprising extracting the respiration signal from electrocardiography signal waveforms during respiration.

17. The method of claim 1 further comprising using an artificial neural network to combine the respiration-SPO2 parameters with other types of patient data to generate output parameters that are used to characterize the biological tissue function.

18. A non-transitory computer readable medium embodying a program of instructions executable by machine to perform steps for heart function analysis, the steps comprising:

receiving patient signal data from a patient, the patient signal data including SPO2 signal data received from an oximeter and indicative of saturation of hemoglobin with oxygen and respiration signal data received from a respiratory monitor;

using a signal data analysis unit to synchronize the SPO2 signal data by gating the SPO2 signal using the respiration signal to select a first cycle of the SPO2 signal which corresponds to expiration of the patient and a second cycle of the SPO2 signal which corresponds to inspiration of the patient;

determining one or more waveform parameters based on the selected cycles of the synchronized SPO2 signal data;

determining one or more respiration-SPO2 parameters based on the one or more waveform parameters;

determining a cardiac arrhythmia classification based on the one or more respiration-SPO2 parameters; and

generating a patient report indicating the determined cardiac arrhythmia classification.

19. A system for heart function analysis, comprising:

a patient monitor comprising an oximeter and a respiratory monitor, the patient monitor for receiving patient signal data from a patient, the patient signal data including SPO2 signal data acquired by the oximeter and indicative of saturation of hemoglobin with oxygen and respiration signal data acquired by the respiratory monitor;

a signal data analysis unit for synchronizing the SPO2 signal data by:

gating the SPO2 signal using the respiration signal to select a first cycle of the SPO2 signal which corresponds to expiration of the patient and a second cycle of the SPO2 signal which corresponds to inspiration of the patient;

determining one or more waveform parameters based on the selected cycles of the synchronized SPO2 signal data;

determining one or more respiration-SPO2 parameters based on the one or more waveform parameters;

determining a heart function based on the one or more respiration-SPO2 parameters; and

an output device for presenting a patient report indicating the determined heart function.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2022
From: ICE CAP
To: PIXART IMAGING INC.
Reel/Frame 061639/0342 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2021
From: ALLIED SECURITY TRUST I
To: ICE CAP, SERIES 106 OF ALLIED SECURITY TRUST I
Reel/Frame 058601/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2021
From: SIEMENS HEALTHCARE GMBH
To: ALLIED SECURITY TRUST I
Reel/Frame 058960/0371 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE OF ASSIGNMENT 3, ASSIGNOR SIEMENS MEDICAL SOLUTIONS USA, INC. TO SIEMENS HEALTHCARE GMBH PREVIOUSLY RECORDED ON REEL 043379 FRAME 0673. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF INVENTOR RIGHTS.. Recorded Dec 2, 2020
From: SIEMENS MEDICAL SOLUTIONS USA, INC.
To: SIEMENS HEALTHCARE GMBH
Reel/Frame 056112/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2017
From: SIEMENS MEDICAL SOLUTIONS USA, INC.
To: SIEMENS HEALTHCARE GMBH
Reel/Frame 043379/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2014
From: ZHANG, HONGXUAN
To: SIEMENS MEDICAL SOLUTIONS USA, INC.
Reel/Frame 032410/0936 →
Continuity (4)
Continuation In Part 13235612 · Sep 19, 2011
Provisional Application 61430244 · Jan 6, 2011
Provisional Application 61804242 · Mar 22, 2013
Related Publication 20140180037A1 · Jun 26, 2014